| Reagan-Udall Foundation

Read more about Oxygen Requirements and Use in Patients With COVID-19 in LMICs

Read more about A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19

Read more about FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol

Read more about The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001

Read more about The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

Read more about CStone Pharmaceuticals (Suzhou) Co., Ltd.

In February, I announced the Center for Tobacco Product’s (CTP) “all-center” approach to responding to the evaluation of our center by an independent expert panel facilitated by the Reagan-Udall Foundation (RUF), including our plans to address the 15 recommendations outlined in the evaluation panel’s report.

Oxygen Requirements and Use in Patients With COVID-19 in LMICs

A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19

FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol

The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

CStone Pharmaceuticals (Suzhou) Co., Ltd.

CTP’s Progress Addressing Recommendations from the Reagan-Udall Evaluation -Statement from CTP Director-

Mortality, Gravity Predictive Factors and Clinical Evolution of Older COVID-19 Patients in Short Geriatric Services.

CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19

A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.

Subscribe for updates from the Reagan-Udall Foundation for the FDA